1. Imaging in Liver Malignancy

2. Program Objectives

3. Clinical Impact of Focal Liver Lesions

4. HCC

5. Contemporary Imaging Approaches

6. Ultrasound

7. Ultrasound Limitations

8. Ultrasound Liver Imaging Reporting and Data System

9. Ultrasound Limited Sensitivity Compared to CECT/MRI

10. Contrast-Enhanced Ultrasound

11. Multi-Detector CT

12. Multi-Detector CT

13. Multiple Phases

14. Injection Rate

15. Cumulative Radiation Dose

16. Radiation Dose

17. Standard Radiation Dose CT Vs Reduced Dose CT

18. Dual Energy CT

19. Low keV

20. Iodine Quantification for Characterization of Indeterminate Liver Lesions

21. Virtual Non-Contrast CT

22. Value of Non-Contrast CT

23. MRI and Advantages Over CT

24. Multiphasic Arterial Phase (I)

25. Multiphasic Arterial Phase (II)

26. MRI and Advantages Over CT

27. Increased Contrast Enhancement at MRI

28. Increased Detection of Capsule and Washout

29. MRI and Advantages Over CT

30. MRI: Fat

31. MRI: Fat Increased Lesion Characterization

32. MRI: Fat (II)

33. MRI and Advantages Over CT

34. HBP Agents Gadoxetate

35. HBP Agents Vascular + Function

36. HBP for Lesion Characterization Adenoma

37. Progression to HCC (I)

38. Progressed HCC

39. Early HCC

40. HCC Grading

41. Microvascular Tumor Invasion

42. HBP for Metastatic Disease (I)

43. HBP for Metastatic Disease (III)

44. Limitations of MRI

45. Different Sequences Acquired in Conventional MRI Examination

46. Abbreviated MRI Protocol for HCC Surveillance

47. Abbreviated MRI Protocol (~ 15 Minutes)

48. Conclusions

49. Abbreviations

50. Abbreviations (cont)